Chinese Vitamin C Makers’ Price-Fixing Trial Set for Nov. 5

China Pharmaceutical Group Ltd. and several other Chinese makers of vitamin C will face a Nov. 5 trial in the U.S. for alleged price-fixing, a federal judge said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.